Search all trials

Find therapies in clinical trials near you – page 51

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 962
countries: 28
conditions: 2 101

3 962 trials recruiting28 European countries2 101 conditions coveredUpdated today

Quick filters

Atrial fibrillation+2

Not recruiting

Registered drug

Study on Asundexian and Apixaban for Preventing Stroke in Adults with Atrial Fibrillation at Risk for Stroke

Registered drug

France

Participants:18–64 years · 65+ years
Substances:Apixaban

Contact Research Centre

Optic atrophy

Not recruiting

Registered drugNo placebo

Study on the Safety and Effects of Nicotinamide for Patients with Dominant Optic Atrophy

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Nicotinamide

Contact Research Centre

Malignant melanoma

Not recruiting

Registered drug

Study Comparing Pembrolizumab and Placebo for Patients with Resected High-Risk Stage II Melanoma

Registered drug

France

Participants:0–17 years · 18–64 years · 65+ years
Substances:Pembrolizumab

Contact Research Centre

Non-small cell lung cancer metastatic

Not recruiting

Registered drugNo placebo

Study Comparing MK-7684A with Chemotherapy to Pembrolizumab with Chemotherapy for Patients with Metastatic Non-Small Cell Lung Cancer

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Carboplatin

Contact Research Centre

Prostate cancer

Not recruiting

Registered drug

Study of Apalutamide and Androgen Deprivation Therapy for Patients with High-Risk Prostate Cancer

Registered drug

France

Participants:18–64 years · 65+ years
Substances:Apalutamide

Contact Research Centre

Myelodysplastic syndrome

Not recruiting

Registered drugNo placebo

Study Comparing Luspatercept and Epoetin Alfa for Treating Anemia in Patients with Low-Risk Myelodysplastic Syndrome Who Are Not Dependent on Blood Transfusions

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Epoetin Alfa

Contact Research Centre

Prostate cancer

Not recruiting

Registered drug

Study on the Effectiveness and Safety of Apalutamide and GnRH Agonist in Patients with High-Risk Prostate Cancer Undergoing Radiation Therapy

Registered drug

France

Participants:18–64 years · 65+ years
Substances:Apalutamide

Contact Research Centre

Dry eye+1

Not recruiting

Registered drug

Study on Long-Term Safety and Efficacy of Ianalumab for Patients with Sjögren’s Syndrome

Registered drug

France

Participants:18–64 years · 65+ years
Substances:Emtricitabine

Contact Research Centre

Leiomyosarcoma metastatic

Not recruiting

Registered drugNo placebo

Study of Lurbinectedin and Doxorubicin for First-line Treatment in Patients with Metastatic Leiomyosarcoma

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Filgrastim

Contact Research Centre

Squamous cell carcinoma of head and neck

Not recruiting

InvestigationalNo placebo

Study of Tislelizumab, Surzebiclimab, and LBL-007 for Patients with Recurrent or Metastatic Head and Neck Cancer

InvestigationalNo placebo

France

Participants:18–64 years · 65+ years
Substances:Lbl-007

Contact Research Centre

Clear cell renal cell carcinoma

Not recruiting

Registered drug

Study of Belzutifan and Pembrolizumab for Patients with Renal Cell Carcinoma After Surgery

Registered drug

France

Participants:18–64 years · 65+ years
Substances:Belzutifan

Contact Research Centre

Neoplasm malignant

Not recruiting

InvestigationalNo placebo

Study of ART0380 for Patients with Advanced or Metastatic Solid Tumors

InvestigationalNo placebo

France

Participants:18–64 years · 65+ years

Contact Research Centre

Find therapies in clinical trials near you – page 51

674 trials match your criteria

Atrial fibrillation+2

Study on Asundexian and Apixaban for Preventing Stroke in Adults with Atrial Fibrillation at Risk for Stroke

Optic atrophy

Study on the Safety and Effects of Nicotinamide for Patients with Dominant Optic Atrophy

Malignant melanoma

Study Comparing Pembrolizumab and Placebo for Patients with Resected High-Risk Stage II Melanoma

Non-small cell lung cancer metastatic

Study Comparing MK-7684A with Chemotherapy to Pembrolizumab with Chemotherapy for Patients with Metastatic Non-Small Cell Lung Cancer

Prostate cancer

Study of Apalutamide and Androgen Deprivation Therapy for Patients with High-Risk Prostate Cancer

Myelodysplastic syndrome

Study Comparing Luspatercept and Epoetin Alfa for Treating Anemia in Patients with Low-Risk Myelodysplastic Syndrome Who Are Not Dependent on Blood Transfusions

Prostate cancer

Study on the Effectiveness and Safety of Apalutamide and GnRH Agonist in Patients with High-Risk Prostate Cancer Undergoing Radiation Therapy

Dry eye+1

Study on Long-Term Safety and Efficacy of Ianalumab for Patients with Sjögren’s Syndrome

Leiomyosarcoma metastatic

Study of Lurbinectedin and Doxorubicin for First-line Treatment in Patients with Metastatic Leiomyosarcoma

Squamous cell carcinoma of head and neck

Study of Tislelizumab, Surzebiclimab, and LBL-007 for Patients with Recurrent or Metastatic Head and Neck Cancer

Clear cell renal cell carcinoma

Study of Belzutifan and Pembrolizumab for Patients with Renal Cell Carcinoma After Surgery

Neoplasm malignant

Study of ART0380 for Patients with Advanced or Metastatic Solid Tumors

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.